New B-Cell Drug Disappoints in Lupus

(MedPage Today) -- Atacicept, a biologic agent that targets two B-cell factors in patients with moderate-to-severe lupus, failed to meet the primary endpoint in a yearlong phase II/III trial, researchers reported.

Source: MedPage Today Primary Care - June 25, 2014 Category: Primary Care Source Type: news